LRCH4

gene
On this page

Summary

LRCH4 (leucine rich repeats and calponin homology domain containing 4, HGNC:6691) is a protein-coding gene on chromosome 7q22.1, encoding Leucine-rich repeat and calponin homology domain-containing protein 4 (O75427). Accessory protein that regulates signaling by multiple TLRs, acting as a broad-spanning regulator of the innate immune response.

This gene encodes a protein that contains leucine-rich repeats (LRR) at its amino terminus and that is known to be involved in ligand binding. The carboxyl terminus may act as a membrane anchor. Identified structural elements suggest that the encoded protein resembles a receptor.

Source: NCBI Gene 4034 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 154 total — 1 pathogenic
  • MANE Select transcript: NM_002319

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:6691
Approved symbolLRCH4
Nameleucine rich repeats and calponin homology domain containing 4
Location7q22.1
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000077454
Ensembl biotypeprotein_coding
OMIM620165
Entrez4034

Gene structure

Transcript identifiers

Ensembl transcripts: 27 — 19 protein_coding, 7 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000310300, ENST00000467201, ENST00000470184, ENST00000476881, ENST00000485554, ENST00000485583, ENST00000487697, ENST00000490359, ENST00000497245, ENST00000498539, ENST00000877641, ENST00000877642, ENST00000877643, ENST00000877644, ENST00000877645, ENST00000877646, ENST00000877647, ENST00000877648, ENST00000877649, ENST00000877650, ENST00000877651, ENST00000913367, ENST00000913368, ENST00000913369, ENST00000965051, ENST00000965052, ENST00000965053

RefSeq mRNA: 2 — MANE Select: NM_002319 NM_001289934, NM_002319

CCDS: CCDS34706, CCDS94156

Canonical transcript exons

ENST00000310300 — 18 exons

ExonStartEnd
ENSE00000710709100585881100586129
ENSE00002431243100576694100576777
ENSE00002447667100576902100577005
ENSE00003492939100575871100576008
ENSE00003495490100575705100575782
ENSE00003511792100577822100577912
ENSE00003543517100581777100581882
ENSE00003549698100582041100582167
ENSE00003569652100577497100577558
ENSE00003571414100582315100582459
ENSE00003591939100577664100577740
ENSE00003600595100578159100578258
ENSE00003613563100578399100578511
ENSE00003613702100578650100578786
ENSE00003633122100577273100577389
ENSE00003660067100576238100576323
ENSE00003680140100577086100577154
ENSE00003846915100574011100575304

Expression profiles

Bgee: expression breadth ubiquitous, 139 present calls, max score 98.90.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 34.4321 / max 572.6308, expressed in 1819 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
8521733.59121817
852180.4994235
852160.2337103
852150.107732

Top tissues by expression

139 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
granulocyteCL:000009498.90gold quality
right testisUBERON:000453498.57gold quality
left testisUBERON:000453398.54gold quality
bloodUBERON:000017898.40gold quality
spleenUBERON:000210697.86gold quality
pituitary glandUBERON:000000797.02gold quality
leukocyteCL:000073896.98gold quality
testisUBERON:000047396.98gold quality
monocyteCL:000057696.96gold quality
right ovaryUBERON:000211896.86gold quality
left ovaryUBERON:000211996.86gold quality
metanephros cortexUBERON:001053396.79gold quality
adenohypophysisUBERON:000219696.66gold quality
right lobe of thyroid glandUBERON:000111996.59gold quality
left lobe of thyroid glandUBERON:000112096.39gold quality
right lungUBERON:000216796.33gold quality
ovaryUBERON:000099296.15gold quality
small intestine Peyer’s patchUBERON:000345496.08gold quality
nerveUBERON:000102196.01gold quality
tibial nerveUBERON:000132396.01gold quality
vermiform appendixUBERON:000115495.99gold quality
thyroid glandUBERON:000204695.94gold quality
bone marrowUBERON:000237195.91gold quality
minor salivary glandUBERON:000183095.83gold quality
lymph nodeUBERON:000002995.74gold quality
saliva-secreting glandUBERON:000104495.72gold quality
upper lobe of left lungUBERON:000895295.67gold quality
right uterine tubeUBERON:000130295.62gold quality
left uterine tubeUBERON:000130395.61gold quality
right adrenal gland cortexUBERON:003582795.61gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.89

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

78 targeting LRCH4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6127100.0066.762188
HSA-MIR-9-5P100.0072.282361
HSA-MIR-4283100.0066.422097
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-4510100.0066.602050
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-8485100.0077.574731
HSA-MIR-4789-5P99.9870.762721
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-185-3P99.9567.011743
HSA-MIR-6768-5P99.9267.361942
HSA-MIR-124-3P99.8973.743043
HSA-MIR-506-3P99.8973.553057
HSA-MIR-7162-3P99.8968.161682
HSA-MIR-605-3P99.8869.221833
HSA-LET-7A-2-3P99.8770.531921
HSA-LET-7G-3P99.8570.431929
HSA-MIR-4728-5P99.8569.394718
HSA-MIR-3121-3P99.8271.963630
HSA-MIR-6785-5P99.8268.684428
HSA-MIR-320A-3P99.7769.732107

Literature-anchored findings (GeneRIF, showing 1)

  • Using two bioinformatics pipelines for analysis of RNA fingerprints we identified significant effects of E. coli on the mRNAs HMBS, ATP2C1 and LRCH4. To see whether these three proteins were present in platelets and were influenced by the bacteria, we analysed HMBS, ATP2C1 and LRCH4 in platelet lysates and releasates by Western blot and ELISA. (PMID:30385858)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusLrch4ENSMUSG00000093445
rattus_norvegicusLrch4ENSRNOG00000001402

Paralogs (31): LRRC7 (ENSG00000033122), PHLPP2 (ENSG00000040199), LRRC40 (ENSG00000066557), PHLPP1 (ENSG00000081913), SHOC2 (ENSG00000108061), ERBIN (ENSG00000112851), LRRC39 (ENSG00000122477), LRCH2 (ENSG00000130224), LRCH1 (ENSG00000136141), LRRC8A (ENSG00000136802), LRRC1 (ENSG00000137269), MFHAS1 (ENSG00000147324), LRRC27 (ENSG00000148814), LRRK1 (ENSG00000154237), LRRC58 (ENSG00000163428), LRRC2 (ENSG00000163827), LRRC18 (ENSG00000165383), LRRC28 (ENSG00000168904), LRRC8E (ENSG00000171017), LRRC8C (ENSG00000171488), LRRC8D (ENSG00000171492), PIDD1 (ENSG00000177595), SCRIB (ENSG00000180900), LRCH3 (ENSG00000186001), LRRIQ4 (ENSG00000188306), LRRC8B (ENSG00000197147), LRRC10 (ENSG00000198812), LRRC10B (ENSG00000204950), LRRC30 (ENSG00000206422), LRRC69 (ENSG00000214954), LRRD1 (ENSG00000240720)

Protein

Protein identifiers

Leucine-rich repeat and calponin homology domain-containing protein 4O75427 (reviewed: O75427)

Alternative names: Leucine-rich repeat neuronal protein 4

All UniProt accessions (2): O75427, H7C5D9

UniProt curated annotations — full annotation on UniProt →

Function. Accessory protein that regulates signaling by multiple TLRs, acting as a broad-spanning regulator of the innate immune response. In macrophages, binds LPS and promotes proper docking of LPS in lipid raft membrane. May be required for lipid raft maintenance.

Subcellular location. Cell membrane.

RefSeq proteins (2): NP_001276863, NP_002310* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR001611Leu-rich_rptRepeat
IPR001715CH_domDomain
IPR003591Leu-rich_rpt_typical-subtypRepeat
IPR032675LRR_dom_sfHomologous_superfamily
IPR036872CH_dom_sfHomologous_superfamily
IPR050216LRR_domain-containingFamily

Pfam: PF00307, PF13855

UniProt features (41 total): modified residue 13, repeat 9, compositionally biased region 7, region of interest 4, sequence conflict 4, chain 1, transmembrane region 1, domain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75427-F164.980.25

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (13): 279, 281, 304, 307, 309, 313, 432, 457, 511, 513, 517, 521, 589

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 366 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP, GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP, GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, RNGTGGGC_UNKNOWN, MCLACHLAN_DENTAL_CARIES_UP, GOBP_SYNAPSE_ASSEMBLY, GOBP_MEMBRANE_BIOGENESIS, GCANCTGNY_MYOD_Q6, TTTGTAG_MIR520D, MODULE_45, AREB6_03, AAGCCAT_MIR135A_MIR135B, GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY

GO Biological Process (3): membrane raft assembly (GO:0001765), nervous system development (GO:0007399), positive regulation of toll-like receptor signaling pathway (GO:0034123)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (3): plasma membrane (GO:0005886), PML body (GO:0016605), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
membrane raft organization1
membrane assembly1
system development1
toll-like receptor signaling pathway1
regulation of toll-like receptor signaling pathway1
positive regulation of pattern recognition receptor signaling pathway1
binding1
membrane1
cell periphery1
nuclear body1
cellular anatomical structure1

Protein interactions and networks

STRING

1680 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LRCH4PMS2P11Q13670496
LRCH4LRRC4Q9HBW1476
LRCH4AGFG2O95081443
LRCH4LRRC4CQ9HCJ2439
LRCH4LRRN3Q9H3W5435
LRCH4LRRN2O75325433
LRCH4SUMF1Q8NBK3420
LRCH4ANKRD46Q86W74403
LRCH4CNTN4Q8IWV2400
LRCH4ACAP1Q15027394
LRCH4LRCH1Q9Y2L9389
LRCH4GNB2P11016385
LRCH4HTR2CP28335373
LRCH4NUDT6P53370373
LRCH4LRRC3BQ96PB8349

IntAct

72 interactions, top by confidence:

ABTypeScore
DOCK8LRCH4psi-mi:“MI:0914”(association)0.620
MDFILRCH4psi-mi:“MI:0915”(physical association)0.620
DOCK8LRCH4psi-mi:“MI:0403”(colocalization)0.620
LRCH4MDFIpsi-mi:“MI:0915”(physical association)0.620
LRCH4KRTAP10-7psi-mi:“MI:0915”(physical association)0.560
LRCH4KRTAP10-8psi-mi:“MI:0915”(physical association)0.560
LRCH4KRT40psi-mi:“MI:0915”(physical association)0.560
LRCH4NOTCH2NLApsi-mi:“MI:0915”(physical association)0.560
KRTAP10-8LRCH4psi-mi:“MI:0915”(physical association)0.560
KRT40LRCH4psi-mi:“MI:0915”(physical association)0.560
NOTCH2NLALRCH4psi-mi:“MI:0915”(physical association)0.560
LRCH4RETREG3psi-mi:“MI:0915”(physical association)0.560
LRCH4KASH5psi-mi:“MI:0915”(physical association)0.560
LRCH4HSD17B11psi-mi:“MI:0915”(physical association)0.560
LRCH4CYB5R3psi-mi:“MI:0915”(physical association)0.560
ELOVL7LRCH4psi-mi:“MI:0915”(physical association)0.560
LRCH4RNASEKpsi-mi:“MI:0915”(physical association)0.560
DOCK7LRCH4psi-mi:“MI:0915”(physical association)0.560
LRCH4DOCK7psi-mi:“MI:0914”(association)0.560
LRCH4RTN4psi-mi:“MI:0915”(physical association)0.550
LRCH4DOCK6psi-mi:“MI:0915”(physical association)0.500

BioGRID (51): LRCH4 (Affinity Capture-MS), KRT40 (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-8 (Two-hybrid), NOTCH2NL (Two-hybrid), RTN4 (Two-hybrid), MDFI (Two-hybrid), LRCH4 (Affinity Capture-MS), LRCH4 (Affinity Capture-MS), LRCH4 (Two-hybrid), LRCH4 (Proximity Label-MS), LRCH4 (Proximity Label-MS), LRCH4 (Affinity Capture-MS), LRCH4 (Affinity Capture-MS), LRCH4 (Two-hybrid)

ESM2 similar proteins: A0A8P0N4K0, A2AB59, B4F7F3, D3YZU1, D3ZD05, O35681, O75427, O95382, P22455, P22607, P40748, P55144, P70218, Q06418, Q14160, Q1LZH7, Q2PS20, Q32P44, Q495M9, Q4ACU6, Q4H4B6, Q505F5, Q5F488, Q61851, Q63ZY3, Q6P9K8, Q6TLK4, Q6ZUM4, Q7KRY7, Q80T11, Q80U72, Q8BH60, Q8BX02, Q8N1G4, Q8TE68, Q8VC03, Q8VHK1, Q8VHK2, Q8WXD9, Q8WXE0

Diamond homologs: O75427, P26932, P41737, P52735, P62046, Q3UMG5, Q5S006, Q5VUJ6, Q60992, Q6Z8P4, Q8BVU0, Q921G6, Q96II8, Q9R0C8, Q9Y2L9, B9EUM5, B9G8P1, O14188, P14318, P15498, P19966, P27870, P31232, P37397, P37802, P37803, P37804, P37805, P51911, P54100, Q01995, Q08091, Q08092, Q08093, Q08094, Q08290, Q08DN7, Q14155, Q15052, Q15417

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

154 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance112
Likely benign8
Benign2

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
563415GRCh37/hg19 7q22.1(chr7:98847725-102472176)x1Pathogenic

SpliceAI

2192 predictions. Top by Δscore:

VariantEffectΔscore
7:100575715:C:CAdonor_gain1.0000
7:100575745:T:Adonor_gain1.0000
7:100575778:TTTGG:Tacceptor_gain1.0000
7:100575779:TTGG:Tacceptor_gain1.0000
7:100575780:TGG:Tacceptor_gain1.0000
7:100575781:GG:Gacceptor_gain1.0000
7:100575783:C:CCacceptor_gain1.0000
7:100575783:C:CGacceptor_loss1.0000
7:100575784:T:Aacceptor_loss1.0000
7:100575788:G:Cacceptor_gain1.0000
7:100575788:G:GCacceptor_gain1.0000
7:100575792:G:Cacceptor_gain1.0000
7:100575792:G:GCacceptor_gain1.0000
7:100575867:TGACC:Tdonor_loss1.0000
7:100575868:GAC:Gdonor_loss1.0000
7:100575869:A:ACdonor_gain1.0000
7:100575869:A:ATdonor_loss1.0000
7:100575870:C:CCdonor_gain1.0000
7:100575870:CCA:Cdonor_gain1.0000
7:100575918:G:Cdonor_gain1.0000
7:100576009:C:CAacceptor_loss1.0000
7:100576013:C:CTacceptor_gain1.0000
7:100576014:A:Tacceptor_gain1.0000
7:100576015:G:Cacceptor_gain1.0000
7:100576015:G:GCacceptor_gain1.0000
7:100576017:G:Cacceptor_gain1.0000
7:100576017:G:GCacceptor_gain1.0000
7:100576023:CACA:Cacceptor_gain1.0000
7:100576026:A:Cacceptor_gain1.0000
7:100576233:CTCA:Cdonor_loss1.0000

AlphaMissense

4309 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:100582324:A:GL119P1.000
7:100582377:A:CN101K1.000
7:100582377:A:TN101K1.000
7:100578660:G:TP242Q0.999
7:100578674:G:CN237K0.999
7:100578674:G:TN237K0.999
7:100578743:G:CN214K0.999
7:100578743:G:TN214K0.999
7:100578759:A:GL209P0.999
7:100581809:A:TV189D0.999
7:100581815:A:GL187P0.999
7:100581868:G:CN169K0.999
7:100581868:G:TN169K0.999
7:100582042:A:GL164P0.999
7:100582042:A:TL164H0.999
7:100582095:G:CN146K0.999
7:100582095:G:TN146K0.999
7:100582096:T:AN146I0.999
7:100582097:T:AN146Y0.999
7:100582111:A:GL141P0.999
7:100582111:A:TL141H0.999
7:100582161:G:CN124K0.999
7:100582161:G:TN124K0.999
7:100582162:T:AN124I0.999
7:100582163:T:CN124D0.999
7:100582324:A:TL119H0.999
7:100582333:A:TL116H0.999
7:100582378:T:AN101I0.999
7:100582393:A:GL96P0.999
7:100582441:A:GF80S0.999

dbSNP variants (sampled 300 via entrez): RS1000004142 (7:100579437 A>G), RS1000083112 (7:100587590 A>C,G), RS1000116950 (7:100574325 T>C), RS1000446188 (7:100574090 T>C), RS1000870684 (7:100584604 G>T), RS1001011367 (7:100580828 G>C,T), RS1001051589 (7:100574981 G>A,T), RS1001232852 (7:100580694 TAAAC>T), RS1001403486 (7:100585632 TAAAGAGAA>T), RS1001627956 (7:100575808 T>C), RS1001743966 (7:100575558 C>T), RS1002248734 (7:100584752 G>C), RS1002870647 (7:100586993 G>A,C), RS1002969267 (7:100583314 C>T), RS1003306602 (7:100582963 A>T)

Disease associations

OMIM: gene MIM:620165 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST006976_69Macular thickness6.000000e-10
GCST010702_48Subcortical volume (MOSTest)6.000000e-10
GCST010703_289Brain morphology (MOSTest)6.000000e-15

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arseniteincreases abundance, increases expression2
Air Pollutantsdecreases expression, affects expression, increases abundance2
Arsenicincreases expression, affects methylation, increases abundance2
aristolochic acid Iincreases expression1
FR900359affects phosphorylation1
triphenyl phosphateaffects expression1
coumarinincreases phosphorylation1
beta-methylcholineaffects expression1
di-n-butylphosphoric acidaffects expression1
lipopolysaccharide, Escherichia coli O111 B4increases expression, increases reaction1
abrineincreases expression1
Pam(3)CSK(4) peptideincreases expression, increases reaction1
eprenetapoptaffects expression, affects reaction1
Decitabineincreases expression1
Acetaminophenincreases expression1
Atrazineincreases expression1
Caffeineaffects phosphorylation1
Camptothecindecreases response to substance1
Carmustinedecreases expression1
Ozoneaffects expression, increases abundance1
Smokedecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Urethaneincreases expression1
Antirheumatic Agentsdecreases expression1
Okadaic Acidincreases expression1
Particulate Matterdecreases expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.